Showing results (141-150 of 187) with videos related to
Sort By:
Pageof 19
American Journal of Clinical Oncology|February 1, 1989
Phase II trial of N-methylformamide in advanced renal cancerJ S Abrams, N Tait, H Silva, et al.Clinical Pharmacology and Therapeutics|July 1, 1982
Cyclophosphamide plasma and cerebrospinal fluid kinetics with and without dimethyl sulfoxideM J Egorin, R S Kaplan, M Salcman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1983
Randomized study of cyclophosphamide, doxorubicin, and etoposide (VP16-213) with or without cisplatinum in non-small cell lung cancerJ Z Fuks, J Aisner, D A Van Echo, et al.Journal of Behavior Therapy and Experimental Psychiatry|December 1, 1984
An exploratory study: the psychoeducational group treatment of drug-refractory unipolar depressionD O Antonuccio, W T Akins, P M Chatham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
A novel pharmacodynamically based approach to dose optimization of carboplatin when used in combination with etoposideC P Belani, M J Egorin, J S Abrams, et al.Cancer|June 8, 2001
Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trialP J Loehrer, M Jiroutek, S Aisner, et al.Blood|August 1, 1983
Alloimmunization prevents the migration of transfused indium-111-labeled granulocytes to sites of infectionJ P Dutcher, C A Schiffer, G S Johnston, et al.The American Journal of the Medical Sciences|June 1, 1986
Special studies of the Hickman catheter of a patient with recurrent bacteremia and candidemiaN S Tchekmedyian, K Newman, M R Moody, et al.American Journal of Clinical Oncology|April 1, 1983
Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lungJ Z Fuks, J Aisner, D A Van Echo, et al.AJR. American Journal of Roentgenology|May 1, 1984
Computed tomography of the chest in small cell lung cancer: potential new prognostic signsN O Whitley, J Z Fuks, E S McCrea, et al.Pageof 19